Pressure BioSciences, Inc.

Pressure BioSciences, Inc.

OOTC:PBIO
0.00
USD
0.00
(0.00%)
-0.83EPS
Nov 24Next Earn

Important Dates

Pressure BioSciences, Inc.'s next confirmed earnings release is scheduled for November 24, 2026.

Earnings Date11/24/2026

Share Statistics

As of June 30, 2024, Pressure BioSciences, Inc. has 54.04M shares outstanding.

Shares Outstanding54.04M

Financial Position

As of June 30, 2024, Pressure BioSciences, Inc. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -78.42, indicating conservative leverage, while an interest coverage ratio of -0.54 demonstrates limited ability to service its debt obligations.

Current Ratio0.02
Debt / Equity-78.42
Debt / EBITDA-3.66
Interest Coverage-0.54

Financial Efficiency

USD

These figures cover the twelve months ended June 30, 2024. Return on assets (ROA) is negative at -718.28, reflecting losses generated across the asset base. The company generates approximately 92,086.71 in revenue per employee across its workforce of 16.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.14 indicates how many times Pressure BioSciences, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-718.28
Revenue Per Employee92,086.71
Employee Count16.25
Inventory Turnover2.14

Stock Price Statistics

As of the close on November 13, 2026, Pressure BioSciences, Inc.'s stock has declined approximately 83.33% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

52-Week Price Change-83.33%

Income Statement

USD

Over the twelve months ended June 30, 2024, Pressure BioSciences, Inc. generated 1.50M in revenue and converted that into -30.72M in net income, yielding earnings per share of -0.83. EBITDA reached -7.98M, while operating income came in at -8.20M.

Revenue1.50M
Gross Profit322,584.00
Operating Income-8.20M
Pretax Income-30.72M
Net Income-30.72M
EBITDA-7.98M
EBIT-8.20M
Earnings Per Share (EPS)-0.83

Balance Sheet

USD

As of June 30, 2024, Pressure BioSciences, Inc. holds 14,253.00 in cash and equivalents against 29.19M in total debt, resulting in a net debt position of 28.61M. Total book value stands at -37.23M, with working capital of -42.70M providing operational flexibility.

Cash & Cash Equivalents14,253.00
Total Debt29.19M
Net Debt28.61M
Equity (Book Value)-37.23M
Book Value Per Share-0.69
Working Capital-42.70M

Cash Flow

USD

Pressure BioSciences, Inc. produced -4.43M in operating cash flow over the twelve months ended June 30, 2024. After subtracting -4,495.00 in capital expenditures, free cash flow totaled -4.43M - equivalent to -0.12 per share.

Operating Cash Flow-4.43M
Capital Expenditures-4,495.00
Free Cash Flow-4.43M
FCF Per Share-0.12

Margins

Over the twelve months ended June 30, 2024, Pressure BioSciences, Inc. posted a gross margin of 21.56, reflecting its pricing power and cost economics. The operating margin of -547.79 and net profit margin of -2,053.23 provide insight into operational efficiency.

Gross Margin21.56
Operating Margin-547.79
Pretax Margin-2,053.23
Profit Margin-2,053.23
EBITDA Margin-532.97

Dividends & Yields

These figures cover the twelve months ended June 30, 2024. The dividend payout ratio of 7.60 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Payout Ratio7.60

Stock Splits

Pressure BioSciences, Inc.'s most recent stock split took place on June 5, 2017 with a 30:1 split ratio.

Last Split Date6/5/2017
Split Ratio30:1